The document contains preliminary report on all aspects of WHO’s response in the Ebola outbreak. WHO Member States will discuss the report at the sixty-eighth World Health Assembly.
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...n WHA 70.16, which calls on Member States to develop or adapt national vector control strategies and operational plans to align with this strategy.
more
A Snapshot of European Collection Schemes
Improve identification, verification, communication and coordination.
Learning from the Use of Data, Information, and Digital Technologies in the West Africa Ebola Outbreak Response
Available in English, French and Spanish
A Resource Book of Inclusive Practices
…voices of persons with disabilities - Part 1
A review of policy and practice; zero Hunger Phase 1
Case Studies on Building Resilience in the Horn of Africa
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,... the introduction of mechanized tools in the mining sector rapidly increased levels of silica exposure, resulting in an increase in cases and our understanding of silicosis.
more
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la... réunion au nom du Dr M. Chan, directeur-général de l’OMS.
La THA est une maladie qui afflige les populations rurales de l’Afrique, là où prolifère la mouche tsé-tsé (ou glossine), vecteur des trypanosomes qui en sont la cause. On distingue deux formes de THA : la forme à T. b. gambiense ou forme gambienne, endémique en Afrique de l’Ouest et en Afrique centrale et qui
représente actuellement 95 % des cas, et la forme à T. b. rhodesiense ou forme rhodésienne, endémique en Afrique de l’Est et en Afrique australe, à laquelle sont dus les 5 % restants.
more
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Scaling Up Multi-Sectoral Efforts to Establish a Strong Nutrition Foundation for Uganda’s Development
Mid-term review of The National AIDS Programme 2011-15
October 2013
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
September Highlights
Ebola prevention measures began in South Sudan with three border screening points established
Nearly 160,000 people reached with WASH services throughout South Sudan
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation